CL
MRNA icon

CSS LLC’s Moderna MRNA Stock Holding History

CSS LLC’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,700
Closed -$665K – 841
2022
Q4 		$665K Sell
3,700
-23,800
-87% -$3.89M 0.04% 331
2022
Q3 		$3.25M Buy
27,500
+15,000
+120% +$2.28M 0.15% 150
2022
Q2 		$1.78M Sell
12,500
-2,000
-14% -$286K 0.07% 307
2022
Q1 		$2.5M Buy
+14,500
New +$2.44M 0.09% 224
2021
Q4 		– Sell
-6,500
Closed -$2.5M – 1292
2021
Q3 		$2.5M Sell
6,500
-76,100
-92% -$28.1M 0.11% 191
2021
Q2 		$19.4M Buy
82,600
+34,600
+72% +$6.18M 0.8% 20
2021
Q1 		$6.29M Buy
48,000
+31,800
+196% +$4.61M 0.26% 62
2020
Q4 		$1.69M Buy
16,200
+6,200
+62% +$627K 0.06% 217
2020
Q3 		$708K Buy
+10,000
New +$697K 0.03% 360
2020
Q2 		– Sell
-20,900
Closed -$627K – 739
2020
Q1 		$627K Buy
+20,900
New +$481K 0.05% 262

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CSS LLC's MRNA Position: Q1 2022 in Review

CSS LLC sold out of Moderna (MRNA) in Q1 2022, closing a stake of 3,871 shares — an estimated $652K sold.

CSS LLC first reported a position in MRNA in Q1 2020 and held it in 6 quarters. The position peaked at $3.44M in Q2 2020. 1,006 funds tracked by Wall St. Rank hold MRNA as of Q1 2022.

  • CSS LLC reported no remaining Moderna position as of Q1 2022 after selling out during the quarter.
  • CSS LLC sold 3,871 Moderna shares in Q1 2022, an estimated $652K.
  • CSS LLC first reported a position in Moderna in Q1 2020 and held it in 6 quarters.
  • CSS LLC's Moderna position peaked at $3.44M in Q2 2020.
  • 1,006 funds tracked by Wall St. Rank held Moderna as of Q1 2022.

Based on CSS LLC's 13F filing for Q1 2022, filed 16 May 2022.